You are currently logged into
Cancer Health Directory - My Account or Log Out
Cancer Health Cancer Health
  • Home
  • News
    • News
    • Newsfeed
    • Science News
    • Features
    • Opinions
    • Conferences
    • Slideshows
    • Cancer Health TV
    • By Author
    • RSS Links
  • Cancer Basics
    • Cancer 101
    • Newly Diagnosed
    • Living with Cancer
    • Cancer Treatment
    • Cancer Medications
    • Breast Cancer
    • Colon Cancer
    • Liver Cancer
    • Lung Cancer
    • Prostate Cancer
    • More Types of Cancer
    • Resources
  • Hot Topics
    • Coronavirus (COVID-19)
    • Health Equity
    • Cancer Treatment
    • Car-T Therapy
    • Caregivers
    • Chemotherapy
    • Immunotherapy
    • Marijuana
    • Mental Health
    • Quality of Life
  • Magazine
    • Magazine
    • Current Issue
    • Archives
    • Digital Editions
    • Cancer Health Focus
    • Bulk Subscriptions
    • Email Newsletters
  • Blogs
    • Blogs
    • Recent Posts
    • Browse Bloggers
    • RSS Links
  • Community
    • Cancer Health Stories
    • Cancer Health Forums
    • Ask Cancer Health
    • Polls
    • Surveys
    • Quizzes
    • Calendar
    • Volunteer Jobs
    • Bookstore
    • Amazon Store
  • About Us
    • About Us
    • Masthead
    • Advertise
    • Awards
    • Contact Us
  • Facebook
  • Twitter

© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

© 2021 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Advertisement

Share


Twitter
Facebook
Pinterest
Tumblr
Email

#GU20

Tweet
  • Share

Harry Nutsickle does GU20

Reporter’s Notebook: Financial Woes and Dodgy Statistics Cross All Cancers (GU20)

Genitourinary Cancers Symposium reaches beyond the latest prostate, bladder and kidney cancer treatments.

Male reproductive system

Zytiga Linked to Better Quality of Life in Men With Prostate Cancer

Men who took Zytiga had higher quality of life scores and less pain than those treated with chemotherapy.

New Targeted Therapy Shows Promise for Kidney Cancer

MK-6482 shrank tumors in 24% of people with advanced renal cell carcinoma.

T cells and dendritic cells

Provenge Prostate Cancer Vaccine Linked to Longer Survival

The personalized vaccine was associated with a 45% lower risk of death in a real-world study.

Padcev Combo Continues to Show Promise for Advanced Bladder Cancer

Updated study results show antibody-drug conjugate plus Keytruda shrinks tumors in 73% of patients.

Advertisement

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.